nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—Cytarabine—lymphatic system cancer	0.833	1	CbGbCtD
Oxprenolol—Abdominal colic—Vincristine—lymphatic system cancer	0.0283	0.17	CcSEcCtD
Oxprenolol—Cardiac failure—Fludarabine—lymphatic system cancer	0.00466	0.028	CcSEcCtD
Oxprenolol—Bronchospasm—Teniposide—lymphatic system cancer	0.0044	0.0264	CcSEcCtD
Oxprenolol—Sweating increased—Fludarabine—lymphatic system cancer	0.00383	0.023	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00338	0.0203	CcSEcCtD
Oxprenolol—Diplopia—Carmustine—lymphatic system cancer	0.00291	0.0175	CcSEcCtD
Oxprenolol—Bronchospasm—Bleomycin—lymphatic system cancer	0.00284	0.017	CcSEcCtD
Oxprenolol—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00277	0.0167	CcSEcCtD
Oxprenolol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00254	0.0153	CcSEcCtD
Oxprenolol—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00249	0.015	CcSEcCtD
Oxprenolol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00246	0.0148	CcSEcCtD
Oxprenolol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00244	0.0147	CcSEcCtD
Oxprenolol—Hypotension—Teniposide—lymphatic system cancer	0.00238	0.0143	CcSEcCtD
Oxprenolol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00236	0.0142	CcSEcCtD
Oxprenolol—Arthralgia—Fludarabine—lymphatic system cancer	0.00233	0.014	CcSEcCtD
Oxprenolol—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00228	0.0137	CcSEcCtD
Oxprenolol—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00219	0.0132	CcSEcCtD
Oxprenolol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00216	0.013	CcSEcCtD
Oxprenolol—Nausea—Mechlorethamine—lymphatic system cancer	0.00205	0.0123	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00204	0.0122	CcSEcCtD
Oxprenolol—Abdominal pain—Teniposide—lymphatic system cancer	0.00201	0.0121	CcSEcCtD
Oxprenolol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00197	0.0118	CcSEcCtD
Oxprenolol—Fatigue—Fludarabine—lymphatic system cancer	0.00193	0.0116	CcSEcCtD
Oxprenolol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00191	0.0115	CcSEcCtD
Oxprenolol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00188	0.0113	CcSEcCtD
Oxprenolol—Asthenia—Teniposide—lymphatic system cancer	0.00183	0.011	CcSEcCtD
Oxprenolol—Pruritus—Teniposide—lymphatic system cancer	0.0018	0.0108	CcSEcCtD
Oxprenolol—Diarrhoea—Teniposide—lymphatic system cancer	0.00174	0.0105	CcSEcCtD
Oxprenolol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00165	0.0099	CcSEcCtD
Oxprenolol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00161	0.00964	CcSEcCtD
Oxprenolol—Asthenia—Fludarabine—lymphatic system cancer	0.0016	0.00964	CcSEcCtD
Oxprenolol—Headache—Teniposide—lymphatic system cancer	0.00159	0.00957	CcSEcCtD
Oxprenolol—Pruritus—Fludarabine—lymphatic system cancer	0.00158	0.0095	CcSEcCtD
Oxprenolol—Hypotension—Bleomycin—lymphatic system cancer	0.00153	0.0092	CcSEcCtD
Oxprenolol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00153	0.00919	CcSEcCtD
Oxprenolol—Nausea—Teniposide—lymphatic system cancer	0.00151	0.00908	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00149	0.00897	CcSEcCtD
Oxprenolol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0014	0.00842	CcSEcCtD
Oxprenolol—Headache—Fludarabine—lymphatic system cancer	0.0014	0.00841	CcSEcCtD
Oxprenolol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00139	0.00834	CcSEcCtD
Oxprenolol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00134	0.00803	CcSEcCtD
Oxprenolol—Hypotension—Carmustine—lymphatic system cancer	0.00134	0.00803	CcSEcCtD
Oxprenolol—Nausea—Fludarabine—lymphatic system cancer	0.00133	0.00798	CcSEcCtD
Oxprenolol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00132	0.00793	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.0013	0.00783	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.0013	0.00782	CcSEcCtD
Oxprenolol—Insomnia—Carmustine—lymphatic system cancer	0.00129	0.00778	CcSEcCtD
Oxprenolol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00129	0.00773	CcSEcCtD
Oxprenolol—Hypotension—Vincristine—lymphatic system cancer	0.00128	0.00767	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00124	0.00748	CcSEcCtD
Oxprenolol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00124	0.00747	CcSEcCtD
Oxprenolol—Insomnia—Vincristine—lymphatic system cancer	0.00124	0.00742	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00121	0.00728	CcSEcCtD
Oxprenolol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00121	0.00726	CcSEcCtD
Oxprenolol—Fatigue—Vincristine—lymphatic system cancer	0.00118	0.00707	CcSEcCtD
Oxprenolol—Asthenia—Bleomycin—lymphatic system cancer	0.00118	0.00707	CcSEcCtD
Oxprenolol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00117	0.00703	CcSEcCtD
Oxprenolol—Pruritus—Bleomycin—lymphatic system cancer	0.00116	0.00697	CcSEcCtD
Oxprenolol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00115	0.00689	CcSEcCtD
Oxprenolol—Abdominal pain—Carmustine—lymphatic system cancer	0.00113	0.0068	CcSEcCtD
Oxprenolol—Abdominal pain—Vincristine—lymphatic system cancer	0.00108	0.00649	CcSEcCtD
Oxprenolol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00105	0.00633	CcSEcCtD
Oxprenolol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00105	0.00632	CcSEcCtD
Oxprenolol—Asthenia—Carmustine—lymphatic system cancer	0.00103	0.00617	CcSEcCtD
Oxprenolol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00101	0.00605	CcSEcCtD
Oxprenolol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00098	0.00589	CcSEcCtD
Oxprenolol—Asthenia—Vincristine—lymphatic system cancer	0.00098	0.00589	CcSEcCtD
Oxprenolol—Diarrhoea—Carmustine—lymphatic system cancer	0.000979	0.00588	CcSEcCtD
Oxprenolol—Nausea—Bleomycin—lymphatic system cancer	0.000974	0.00585	CcSEcCtD
Oxprenolol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000955	0.00573	CcSEcCtD
Oxprenolol—Dizziness—Carmustine—lymphatic system cancer	0.000947	0.00568	CcSEcCtD
Oxprenolol—Diarrhoea—Vincristine—lymphatic system cancer	0.000935	0.00561	CcSEcCtD
Oxprenolol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000911	0.00547	CcSEcCtD
Oxprenolol—Dizziness—Vincristine—lymphatic system cancer	0.000904	0.00543	CcSEcCtD
Oxprenolol—Headache—Carmustine—lymphatic system cancer	0.000897	0.00539	CcSEcCtD
Oxprenolol—Headache—Vincristine—lymphatic system cancer	0.000856	0.00514	CcSEcCtD
Oxprenolol—Nausea—Carmustine—lymphatic system cancer	0.00085	0.00511	CcSEcCtD
Oxprenolol—Headache—Mitoxantrone—lymphatic system cancer	0.000834	0.00501	CcSEcCtD
Oxprenolol—Nausea—Vincristine—lymphatic system cancer	0.000812	0.00487	CcSEcCtD
Oxprenolol—Nausea—Mitoxantrone—lymphatic system cancer	0.00079	0.00475	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—lymphatic system cancer	0.000692	0.00415	CcSEcCtD
Oxprenolol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000649	0.0039	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000641	0.00385	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—lymphatic system cancer	0.00062	0.00372	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000604	0.00363	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—lymphatic system cancer	0.0006	0.0036	CcSEcCtD
Oxprenolol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000584	0.0035	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—lymphatic system cancer	0.000572	0.00343	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000524	0.00315	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000489	0.00293	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—lymphatic system cancer	0.000476	0.00286	CcSEcCtD
Oxprenolol—Pruritus—Methotrexate—lymphatic system cancer	0.000469	0.00282	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000454	0.00272	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—lymphatic system cancer	0.000438	0.00263	CcSEcCtD
Oxprenolol—Headache—Methotrexate—lymphatic system cancer	0.000415	0.00249	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—lymphatic system cancer	0.000394	0.00237	CcSEcCtD
